Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Peter Macsek"'
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 1, p 376 (2021)
Despite constant advances in the field of pediatric oncology, the survival rate of high-risk neuroblastoma patients remains poor. The molecular and genetic features of neuroblastoma, such as MYCN amplification and stemness status, have established th
Externí odkaz:
https://doaj.org/article/efd5948838e3485b8f153bf34cf94e6e
Autor:
Michal Mahdal, Jakub Neradil, Peter Mudry, Silvia Paukovcekova, Iva Staniczkova Zambo, Jiri Urban, Peter Macsek, Lukas Pazourek, Tomas Tomas, Renata Veselska
Publikováno v:
Cancers, Vol 13, Iss 14, p 3543 (2021)
Giant-cell tumor of bone (GCTB) is an intermediate type of primary bone tumor characterized by locally aggressive growth with metastatic potential. The aim of this study was to identify new druggable targets among the cell signaling molecules involve
Externí odkaz:
https://doaj.org/article/0359ddf0f0ab42c5a01569643702929b
Autor:
Jan Skoda, Jakub Neradil, Iva Staniczkova Zambo, Alena Nunukova, Peter Macsek, Karolina Borankova, Viera Dobrotkova, Pavel Nemec, Jaroslav Sterba, Renata Veselska
Publikováno v:
Cancers, Vol 12, Iss 1, p 196 (2020)
Serial xenotransplantation of sorted cancer cells in immunodeficient mice remains the most complex test of cancer stem cell (CSC) phenotype. However, we have demonstrated in various sarcomas that putative CSC surface markers fail to identify CSCs, th
Externí odkaz:
https://doaj.org/article/ce6a6716fcb24b558d97a6cf0d6ad4b0
Autor:
Agnieszka Seretny, Lio Böse, Luise Butthof, Kai Volz, Peter Macsek, Julius Michel, Khwab Sanghvi, Stefan Pusch, Theresa Bunse, DarjusFelix Tschaharganeh
Publikováno v:
39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber.
Autor:
Peter Macsek, Marco Breinig, Lio Böse, Agnieszka Seretny, Luise Butthof, Darjus Tschaharganeh
Publikováno v:
39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber.
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 376, p 376 (2022)
International Journal of Molecular Sciences; Volume 23; Issue 1; Pages: 376
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 23; Issue 1; Pages: 376
International Journal of Molecular Sciences
Despite constant advances in the field of pediatric oncology, the survival rate of high-risk neuroblastoma patients remains poor. The molecular and genetic features of neuroblastoma, such as MYCN amplification and stemness status, have established th
Autor:
Iva Staniczková Zambo, Jiri Urban, Tomáš Tomáš, Michal Mahdal, Jakub Neradil, Renata Veselská, Peter Macsek, Peter Múdry, Silvia Paukovcekova, Lukáš Pazourek
Publikováno v:
Cancers, Vol 13, Iss 3543, p 3543 (2021)
Cancers
Volume 13
Issue 14
Cancers
Volume 13
Issue 14
Simple Summary The purpose of this study was to analyze differential cell signaling in response to denosumab treatment to identify and subsequently inhibit molecular targets in the neoplastic stromal cell population, which poses a risk for tumor recu
Autor:
Viera Dobrotkova, Iva Staniczková Zambo, Renata Veselská, Peter Macsek, Alena Nunukova, Jakub Neradil, Karolina Borankova, Pavel Nemec, Jan Skoda, Jaroslav Sterba
Publikováno v:
Cancers
Cancers, Vol 12, Iss 1, p 196 (2020)
Volume 12
Issue 1
Cancers, Vol 12, Iss 1, p 196 (2020)
Volume 12
Issue 1
Serial xenotransplantation of sorted cancer cells in immunodeficient mice remains the most complex test of cancer stem cell (CSC) phenotype. However, we have demonstrated in various sarcomas that putative CSC surface markers fail to identify CSCs, th